The U.S. has been experiencing its worst year for drug shortages in a decade, with Sanofi and AstraZeneca's new RSV shot for infants as the latest high-profile example.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
